182 related articles for article (PubMed ID: 3496779)
21. Hemodynamic effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart disease.
Legrand V; Vandormael M; Collignon P; Kulbertus HE
Am J Cardiol; 1983 Feb; 51(3):422-6. PubMed ID: 6823856
[TBL] [Abstract][Full Text] [Related]
22. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
[TBL] [Abstract][Full Text] [Related]
23. Hemodynamic effects of intravenous pirmenol.
Morris KG; Phillips HR
Angiology; 1988 Mar; 39(3 Pt 2):321-6. PubMed ID: 3354931
[TBL] [Abstract][Full Text] [Related]
24. Assessment of the inotropic and vasodilator effects of amrinone versus isoproterenol.
Firth BG; Ratner AV; Grassman ED; Winniford MD; Nicod P; Hillis LD
Am J Cardiol; 1984 Dec; 54(10):1331-6. PubMed ID: 6507308
[TBL] [Abstract][Full Text] [Related]
25. Comparative effects of bepridil, diltiazem, nifedipine and verapamil on haemodynamic parameters and myocardial oxygen consumption in anaesthetized dogs.
Beaughard M; Michelin MT; Tisne-Versailles J; Lamar JC
Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):276-96. PubMed ID: 3493742
[TBL] [Abstract][Full Text] [Related]
26. Systemic and coronary hemodynamic effects of bepridil in patients with depressed left ventricular function.
De Marco T; Deedwania P; Chatterjee K
Am J Cardiol; 1992 Apr; 69(11):31D-36D. PubMed ID: 1553889
[TBL] [Abstract][Full Text] [Related]
27. Effect of intravenous metoprolol on left ventricular performance in Q-wave acute myocardial infarction.
Dell'Italia LJ; Walsh RA
Am J Cardiol; 1989 Jan; 63(3):166-71. PubMed ID: 2909996
[TBL] [Abstract][Full Text] [Related]
28. Right ventricular dysfunction following cold potassium cardioplegia.
Christakis GT; Fremes SE; Weisel RD; Ivanov J; Madonik MM; Seawright SJ; McLaughlin PR
J Thorac Cardiovasc Surg; 1985 Aug; 90(2):243-50. PubMed ID: 3875003
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular actions after intravenous and intracoronary administration of the slow channel blocker bepridil.
Verdouw PD; Scheffer MG
Arzneimittelforschung; 1984; 34(1):21-5. PubMed ID: 6608356
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of bepridil, a new antianginal agent: clinical and hemodynamic alterations during the treatment of stable angina pectoris.
Narahara KA; Shapiro W; Weliky I; Park J
Am J Cardiol; 1984 Jan; 53(1):29-34. PubMed ID: 6419578
[TBL] [Abstract][Full Text] [Related]
31. Inotropic effect of nicardipine in patients with heart failure: assessment by left ventricular end-systolic pressure-volume analysis.
Aroney CN; Semigran MJ; Dec GW; Boucher CA; Fifer MA
J Am Coll Cardiol; 1989 Nov; 14(5):1331-8. PubMed ID: 2808990
[TBL] [Abstract][Full Text] [Related]
32. Use of catheter-tip velocity--pressure transducer to evaluate left ventricular function in man: effects of intravenous propranolol.
Klinke WP; Christie LG; Nichols WW; Ray ME; Curry RC; Pepine CJ; Conti CR
Circulation; 1980 May; 61(5):946-54. PubMed ID: 7363437
[TBL] [Abstract][Full Text] [Related]
33. Effect of the second-generation calcium channel blocker nisoldipine on left ventricular contractility in cardiac failure.
Lewis BS; Shefer A; Merdler A; Flugelman MY; Hardoff R; Halon DA
Am Heart J; 1988 Jun; 115(6):1238-44. PubMed ID: 3376841
[TBL] [Abstract][Full Text] [Related]
34. Haemodynamic effects of intravenous amrinone in patients with impaired left ventricular function.
Wilmshurst PT; Thompson DS; Jenkins BS; Coltart DJ; Webb-Peploe MM
Br Heart J; 1983 Jan; 49(1):77-82. PubMed ID: 6821613
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular profile of 5 novel nitrate-esters: a comparative study with nitroglycerin in pigs with and without left ventricular dysfunction.
van Woerkens LJ; van der Giessen WJ; Verdouw PD
Br J Pharmacol; 1991 Sep; 104(1):7-14. PubMed ID: 1786521
[TBL] [Abstract][Full Text] [Related]
36. Hemodynamic and metabolic effects of diltiazem during coronary sinus pacing with particular reference to left ventricular ejection fraction.
Josephson MA; Hopkins J; Singh BN
Am J Cardiol; 1985 Feb; 55(4):286-90. PubMed ID: 3969863
[TBL] [Abstract][Full Text] [Related]
37. Hemodynamic effects of intravenous amiodarone in patients with depressed left ventricular function and recurrent ventricular tachycardia.
Schwartz A; Shen E; Morady F; Gillespie K; Scheinman M; Chatterjee K
Am Heart J; 1983 Oct; 106(4 Pt 2):848-56. PubMed ID: 6613831
[TBL] [Abstract][Full Text] [Related]
38. Ventricular pacing lead location alters systemic hemodynamics and left ventricular function in patients with and without reduced ejection fraction.
Lieberman R; Padeletti L; Schreuder J; Jackson K; Michelucci A; Colella A; Eastman W; Valsecchi S; Hettrick DA
J Am Coll Cardiol; 2006 Oct; 48(8):1634-41. PubMed ID: 17045900
[TBL] [Abstract][Full Text] [Related]
39. Hemodynamic effects of intravenous metoprolol.
Bourdillon PD; Canepa-Anson R; Rickards AF
Am J Cardiol; 1979 Nov; 44(6):1195-200. PubMed ID: 495515
[TBL] [Abstract][Full Text] [Related]
40. The effect of midazolam on left ventricular pump performance and contractility in anesthetized patients with coronary artery disease: effect of preoperative ejection fraction.
Messina AG; Paranicas M; Yao FS; Illner P; Roman MJ; Saba PS; Devereux RB
Anesth Analg; 1995 Oct; 81(4):793-9. PubMed ID: 7574012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
